Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease

October 27, 2014 updated by: Children's Hospital of Philadelphia

Improving Primary Care Follow-up for Adolescents With PID: A Randomized Controlled Trial Using Text Message Reminders

The investigators hypothesize that text message reminders to girls diagnosed with pelvic inflammatory disease (PID) in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The Centers for Disease Control (CDC) recommends that patients diagnosed with pelvic inflammatory disease (PID) receive follow-up care within 72 hours of diagnosis. However, recent studies show that the majority of teenage girls diagnosed with PID do not receive this follow-up care within 72 hours. We hypothesize that text message reminders to girls diagnosed with PID in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.

Study Type

Interventional

Enrollment (Actual)

95

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • The Children's Hospital of Philadelphia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Females aged 15 years and older
  • New diagnosis of PID, as defined by the 2006 CDC minimum criteria for diagnosis of PID, on current ED encounter
  • Determined by attending physician to be appropriate for outpatient treatment

Exclusion Criteria:

  • Patient does not have a cell phone that is capable of receiving text messages
  • Developmental disability
  • Non-English speaking
  • Pregnancy
  • Patient who was enrolled in this study on a prior ED visit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Text Message Reminders
Subjects randomized to the the intervention group will receive a total of 4 text messages on days 2 through 5 to remind them to schedule and attend a PCP follow-up appointment
Patients in the intervention group will receive text messages on their cell phones following discharge from the emergency department reminding them to make an appointment with their primary care provider. Text messages will be sent daily for 4 days after discharge from the ED.
No Intervention: Control Group
The control group will not receive any additional reminders to follow-up with PCP.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
PCP follow-up rates will be used to evaluate the efficacy of text message reminders.
Time Frame: PCP follow-up rates will be assessed 7-14 days after discharge from the ED.
PCP follow-up rates will be assessed 7-14 days after discharge from the ED.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of adolescents who accept text message reminders as an measure of feasibility and acceptability.
Time Frame: 7-14 days after discharge from the ED
The acceptability among adolescents of using text message reminders after ED discharge in adolescents treated in a pediatric ED.
7-14 days after discharge from the ED
Number of adolescents satisfied with ED care between the control group and intervention group as a measure of patient satisfaction.
Time Frame: 7-14 days after ED discharge
Patient satisfaction of ED care when receiving text message reminders.
7-14 days after ED discharge
Type of participant characteristics associated with PCP follow-up as a measure of behavior change, compliance and rate of follow-up care
Time Frame: 7-14 days after ED discharge
Patient characteristics associated with PCP follow-up
7-14 days after ED discharge
Barriers to PCP follow-up from an ED visit to measure use of text message technology and rate of change in follow-up care between groups
Time Frame: 7-14 days after ED visit
Types of barriers encountered to PCP follow-up from an ED visit for PID care to measure rate of change in follow-up care between groups
7-14 days after ED visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cynthia Mollen, MD, MSCE, Children's Hospital of Philadelphia
  • Study Director: Frances Balamuth, MD, PhD, Children's Hospital of Philadelphia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

November 30, 2010

First Submitted That Met QC Criteria

February 17, 2011

First Posted (Estimate)

February 18, 2011

Study Record Updates

Last Update Posted (Estimate)

October 28, 2014

Last Update Submitted That Met QC Criteria

October 27, 2014

Last Verified

October 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Inflammatory Disease

Clinical Trials on Text Message Reminders

3
Subscribe